tradingkey.logo
tradingkey.logo
Search

Immix Biopharma Inc

IMMX
Add to Watchlist
8.320USD
-0.230-2.69%
Close 07-31 16:00ETQuotes delayed by 15 min
580.66MMarket Cap
LossP/E TTM

IMMX Financials

See Immix Biopharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Immix Biopharma Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.18/-0.21
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.89
-16.87%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2020Q4
Financial Indicators
EPS
-19.11%-0.18
-63.24%-0.27
2.21%-0.24
-44.73%-0.22
31.84%-0.15
30.34%-0.16
-5.45%-0.24
35.82%-0.15
-25.75%-0.22
14.45%-0.23
---0.23
---0.24
---0.18
---0.27
----
----
----
----
----
----
----
Net Profit
-122.05%-10.09M
-122.11%-10.69M
-6.10%-7.59M
-50.75%-6.62M
13.62%-4.54M
5.45%-4.81M
-67.02%-7.15M
-22.84%-4.39M
-112.08%-5.26M
-33.94%-5.09M
-178.86%-4.28M
-128.84%-3.58M
-86.15%-2.48M
83.30%-3.80M
-280.66%-1.54M
---1.56M
---1.33M
-2872.31%-22.76M
-246.69%-403.26K
----
---765.58K
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
----
----
----
----
----
----
----
Operating profit
-130.71%-10.80M
-118.43%-10.89M
-3.62%-7.66M
-42.85%-6.72M
16.23%-4.68M
7.23%-4.99M
-63.47%-7.39M
-26.39%-4.70M
-121.76%-5.59M
-41.67%-5.38M
-195.02%-4.52M
-138.36%-3.72M
-89.52%-2.52M
-534.19%-3.79M
-340.64%-1.53M
---1.56M
---1.33M
-289.57%-598.34K
-281.42%-347.99K
----
---153.59K
Net Profit
-122.05%-10.09M
-122.11%-10.69M
-6.10%-7.59M
-50.75%-6.62M
13.62%-4.54M
5.45%-4.81M
-67.02%-7.15M
-22.84%-4.39M
-112.08%-5.26M
-33.94%-5.09M
-178.86%-4.28M
-128.84%-3.58M
-86.15%-2.48M
83.30%-3.80M
-280.66%-1.54M
---1.56M
---1.33M
-2872.31%-22.76M
-246.69%-403.26K
----
---765.58K
Current assets
449.93%92.27M
401.23%101.24M
-27.12%16.58M
-54.90%12.33M
-49.02%16.78M
2.07%20.20M
1.90%22.76M
76.25%27.33M
152.55%32.92M
32.82%19.79M
28.41%22.33M
-18.74%15.51M
-34.87%13.03M
-18.08%14.90M
7059.05%17.39M
6435.97%19.08M
--20.01M
--18.19M
--242.92K
--291.97K
----
Total current liabilities
13.24%10.54M
16.39%10.11M
65.29%10.85M
156.53%10.01M
64.53%9.31M
133.41%8.69M
132.33%6.56M
62.86%3.90M
284.05%5.66M
192.30%3.72M
337.08%2.83M
145.18%2.40M
303.45%1.47M
530.22%1.27M
-90.00%646.46K
-83.70%977.21K
--365.09K
--202.04K
--6.46M
--6.00M
----
Total assets
381.68%95.82M
356.86%104.84M
-20.13%20.08M
-45.78%15.64M
-42.09%19.89M
15.17%22.95M
11.87%25.14M
85.24%28.84M
159.98%34.35M
33.65%19.93M
29.20%22.47M
-18.45%15.57M
-34.00%13.21M
-18.05%14.91M
3412.31%17.40M
5329.19%19.09M
--20.02M
--18.19M
--495.26K
--351.58K
----
Total liabilities
11.20%11.45M
13.90%11.04M
55.66%11.82M
122.10%10.98M
53.35%10.30M
160.54%9.70M
168.65%7.59M
106.38%4.94M
355.94%6.72M
112.88%3.72M
337.08%2.83M
145.18%2.40M
303.45%1.47M
765.33%1.75M
-90.34%646.46K
-84.24%977.21K
--365.09K
--202.04K
--6.69M
--6.20M
----
Total equity
779.38%84.36M
607.83%93.80M
-52.91%8.26M
-80.52%4.65M
-65.28%9.59M
-18.22%13.25M
-10.68%17.55M
81.40%23.89M
135.39%27.63M
23.13%16.20M
17.32%19.65M
-27.28%13.17M
-40.27%11.74M
-26.85%13.16M
370.33%16.75M
409.55%18.11M
--19.65M
--17.99M
---6.20M
---5.85M
----
Net operating income
-483.17%-9.83M
-647.16%-11.03M
-46.32%-5.91M
-1.02%-5.31M
55.97%-1.69M
44.87%-1.48M
-30.76%-4.04M
-49.52%-5.26M
-82.93%-3.83M
31.42%-2.68M
-111.06%-3.09M
-542.58%-3.52M
-39.95%-2.09M
-250.41%-3.90M
-2781.24%-1.46M
---547.07K
---1.49M
-800.98%-1.11M
29.23%-50.76K
----
--158.93K
Net investment
-6989.98%-4.80M
-1210.46%-6.65M
-37.16%-372.46K
-31.48%-127.63K
77.57%-67.71K
-3748.76%-507.15K
-597.84%-271.54K
---97.07K
---301.91K
---13.18K
---38.91K
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
--0.00
Net financing
---37.56K
--95.67M
--10.61M
--1.11M
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
13311.62%15.95M
38.28%586.69K
--10.07M
4527.64%4.69M
-95.92%118.92K
-97.73%424.28K
100.00%0.00
---105.96K
--2.91M
--18.72M
---18.35K
----
--0.00

FAQs

What are the current assets of Immix Biopharma Inc?

According to Immix Biopharma Inc's FY2025 earnings report, its current assets were 101.24M, with a year-on-year change of 401.23.

What are the total assets of Immix Biopharma Inc?

According to Immix Biopharma Inc's FY2025 earnings report, its total assets of Immix Biopharma Inc were 104.84M, with a year-on-year change of 356.86.

What are the total liabilities of Immix Biopharma Inc?

According to Immix Biopharma Inc's FY2025 earnings report, its total liabilities of Immix Biopharma Inc were 11.04M, with a year-on-year change of 13.90.

What is the total equity of Immix Biopharma Inc?

According to Immix Biopharma Inc's FY2025 earnings report, its total equity of Immix Biopharma Inc was 93.80M, with a year-on-year change of 607.83.

What is the net operating income of Immix Biopharma Inc?

According to Immix Biopharma Inc's FY2025 earnings report, its net operating income of Immix Biopharma Inc was -29.96M, with a year-on-year change of -32.11.

What is the net investment of Immix Biopharma Inc?

According to Immix Biopharma Inc's FY2025 earnings report, its net investment of Immix Biopharma Inc was -7.21M, with a year-on-year change of -512.54.

What is the net financing of Immix Biopharma Inc?

According to Immix Biopharma Inc's FY2025 earnings report, its net financing of Immix Biopharma Inc was 107.39M, with a year-on-year change of 573.33.

What is the Earnings Per Share (EPS) of Immix Biopharma Inc?

According to Immix Biopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.89, with a year-on-year change of -16.87.

What is the net income of Immix Biopharma Inc?

According to Immix Biopharma Inc's FY2025 earnings report, its net income was -29.44M, with a year-on-year change of -36.21.

What is the Return on Equity (ROE) of Immix Biopharma Inc?

According to Immix Biopharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -55.00, with a year-on-year change of 62.27.

What is the Return on Assets (ROA) of Immix Biopharma Inc?

According to Immix Biopharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -46.07, with a year-on-year change of 54.48.

What is the operating profit of Immix Biopharma Inc?

According to Immix Biopharma Inc's FY2025 earnings report, its operating profit was -29.96M, with a year-on-year change of -32.11.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.